Eosinophilic Disease - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. Eosinophilic Disease Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Eosinophilic Disease Market Restraints
Table 3. Eosinophilic Disease Market Trends
Table 4. Eosinophilic Disease Industry Policy
Table 5. Global Eosinophilic Disease Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Eosinophilic Disease Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Eosinophilic Disease Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Eosinophilic Disease Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Eosinophilic Disease Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Eosinophilic Disease Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Eosinophilic Disease Mergers & Acquisitions, Expansion Plans
Table 12. Global Eosinophilic Disease Manufacturers Product Type
Table 13. Head Office and Eosinophilic Disease Production Site of Key Manufacturer
Table 14. Eosinophilic Disease Capacity of Major Manufacturers and Future Plan
Table 15. China Eosinophilic Disease Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Eosinophilic Disease Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Eosinophilic Disease Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Eosinophilic Disease Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Eosinophilic Disease Production by Region, 2018-2023, (K Units)
Table 20. Global Eosinophilic Disease Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Eosinophilic Disease Upstream (Raw Materials)
Table 22. Global Eosinophilic Disease Typical Customers
Table 23. Eosinophilic Disease Typical Distributors
Table 24. By Type, Global Eosinophilic Disease Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Eosinophilic Disease Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Eosinophilic Disease Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Eosinophilic Disease Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Eosinophilic Disease Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Eosinophilic Disease Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Eosinophilic Disease Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Eosinophilic Disease Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Eosinophilic Disease Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Eosinophilic Disease Sales Quantity Market Share, 2018-2029
Table 34. Takeda Pharmaceutical Company Limited Company Information, Head Office, Market Area, and Industry Position
Table 35. Takeda Pharmaceutical Company Limited Eosinophilic Disease Models, Specifications, and Application
Table 36. Takeda Pharmaceutical Company Limited Eosinophilic Disease Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Takeda Pharmaceutical Company Limited Company Profile and Main Business
Table 38. Takeda Pharmaceutical Company Limited Recent Developments
Table 39. Ellodi Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 40. Ellodi Pharmaceuticals Eosinophilic Disease Models, Specifications, and Application
Table 41. Ellodi Pharmaceuticals Eosinophilic Disease Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Ellodi Pharmaceuticals Company Profile and Main Business
Table 43. Ellodi Pharmaceuticals Recent Developments
Table 44. Bristol-Myers Squibb Company Company Information, Head Office, Market Area, and Industry Position
Table 45. Bristol-Myers Squibb Company Eosinophilic Disease Models, Specifications, and Application
Table 46. Bristol-Myers Squibb Company Eosinophilic Disease Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Bristol-Myers Squibb Company Company Profile and Main Business
Table 48. Bristol-Myers Squibb Company Recent Developments
Table 49. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 50. AstraZeneca Eosinophilic Disease Models, Specifications, and Application
Table 51. AstraZeneca Eosinophilic Disease Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. AstraZeneca Company Profile and Main Business
Table 53. AstraZeneca Recent Developments
Table 54. GSK plc Company Information, Head Office, Market Area, and Industry Position
Table 55. GSK plc Eosinophilic Disease Models, Specifications, and Application
Table 56. GSK plc Eosinophilic Disease Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. GSK plc Company Profile and Main Business
Table 58. GSK plc Recent Developments
Table 59. Regeneron Pharmaceuticals Inc Company Information, Head Office, Market Area, and Industry Position
Table 60. Regeneron Pharmaceuticals Inc Eosinophilic Disease Models, Specifications, and Application
Table 61. Regeneron Pharmaceuticals Inc Eosinophilic Disease Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Regeneron Pharmaceuticals Inc Company Profile and Main Business
Table 63. Regeneron Pharmaceuticals Inc Recent Developments
Table 64. Allakos Inc Company Information, Head Office, Market Area, and Industry Position
Table 65. Allakos Inc Eosinophilic Disease Models, Specifications, and Application
Table 66. Allakos Inc Eosinophilic Disease Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Allakos Inc Company Profile and Main Business
Table 68. Allakos Inc Recent Developments
Table 69. Arena Pharmaceuticals Ltd Company Information, Head Office, Market Area, and Industry Position
Table 70. Arena Pharmaceuticals Ltd Eosinophilic Disease Models, Specifications, and Application
Table 71. Arena Pharmaceuticals Ltd Eosinophilic Disease Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Arena Pharmaceuticals Ltd Company Profile and Main Business
Table 73. Arena Pharmaceuticals Ltd Recent Developments
Table 74. Revolo Biotherapeutics Company Information, Head Office, Market Area, and Industry Position
Table 75. Revolo Biotherapeutics Eosinophilic Disease Models, Specifications, and Application
Table 76. Revolo Biotherapeutics Eosinophilic Disease Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Revolo Biotherapeutics Company Profile and Main Business
Table 78. Revolo Biotherapeutics Recent Developments
Table 79. DBV Technologies Company Information, Head Office, Market Area, and Industry Position
Table 80. DBV Technologies Eosinophilic Disease Models, Specifications, and Application
Table 81. DBV Technologies Eosinophilic Disease Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. DBV Technologies Company Profile and Main Business
Table 83. DBV Technologies Recent Developments
Table 84. Cipla Inc Company Information, Head Office, Market Area, and Industry Position
Table 85. Cipla Inc Eosinophilic Disease Models, Specifications, and Application
Table 86. Cipla Inc Eosinophilic Disease Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Cipla Inc Company Profile and Main Business
Table 88. Cipla Inc Recent Developments
Table 89. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
Table 90. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Models, Specifications, and Application
Table 91. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Sun Pharmaceutical Industries Ltd Company Profile and Main Business
Table 93. Sun Pharmaceutical Industries Ltd Recent Developments
Table 94. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 95. Sanofi Eosinophilic Disease Models, Specifications, and Application
Table 96. Sanofi Eosinophilic Disease Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Sanofi Company Profile and Main Business
Table 98. Sanofi Recent Developments
List of Figures
Figure 1. Eosinophilic Disease Picture
Figure 2. Global Eosinophilic Disease Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Eosinophilic Disease Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Eosinophilic Disease Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Eosinophilic Disease Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Eosinophilic Disease Sales Quantity (K Units) & (2018-2029)
Figure 7. China Eosinophilic Disease Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Eosinophilic Disease Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Eosinophilic Disease Market Share of Global, 2018-2029
Figure 10. Global Eosinophilic Disease Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Eosinophilic Disease Key Participants, Market Share, 2022
Figure 12. Global Eosinophilic Disease Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Eosinophilic Disease Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Eosinophilic Disease Production Market Share & Forecast by Region, 2018-2029
Figure 15. Eosinophilic Disease Industry Chain
Figure 16. Eosinophilic Disease Procurement Model
Figure 17. Eosinophilic Disease Sales Model
Figure 18. Eosinophilic Disease Sales Channels, Direct Sales, and Distribution
Figure 19. Corticosteroids
Figure 20. Monoclonal Antibodies
Figure 21. Anti-cytokine Drug
Figure 22. Cytotoxic Drug
Figure 23. By Type, Global Eosinophilic Disease Consumption Value, 2018-2029, US$ Million
Figure 24. By Type, Global Eosinophilic Disease Consumption Value Market Share, 2018-2029
Figure 25. By Type, Global Eosinophilic Disease Sales Quantity, 2018-2029, (K Units)
Figure 26. By Type, Global Eosinophilic Disease Sales Quantity Market Share, 2018-2029
Figure 27. By Type, Global Eosinophilic Disease Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 28. Eosinophilic Esophagitis
Figure 29. Eosinophilic Granulomatosis with Polyangiitis
Figure 30. Hyper-eosinophilic Syndrome
Figure 31. Nasal Polyposis
Figure 32. Other
Figure 33. By Application, Global Eosinophilic Disease Consumption Value, 2018-2029, US$ Million
Figure 34. By Application, Global Eosinophilic Disease Consumption Value Market Share, 2018-2029
Figure 35. By Application, Global Eosinophilic Disease Sales Quantity, 2018-2029, (K Units)
Figure 36. By Application, Global Eosinophilic Disease Sales Quantity Market Share, 2018-2029
Figure 37. By Application, Global Eosinophilic Disease Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 38. By Region, Global Eosinophilic Disease Consumption Value Market Share, 2018-2029
Figure 39. By Region, Global Eosinophilic Disease Sales Quantity Market Share, 2018-2029
Figure 40. North America Eosinophilic Disease Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, North America Eosinophilic Disease Consumption Value Market Share, 2022
Figure 42. Europe Eosinophilic Disease Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, Europe Eosinophilic Disease Consumption Value Market Share, 2022
Figure 44. Asia Pacific Eosinophilic Disease Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country/Region, Asia Pacific Eosinophilic Disease Consumption Value Market Share, 2022
Figure 46. South America Eosinophilic Disease Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, South America Eosinophilic Disease Consumption Value Market Share, 2022
Figure 48. Middle East & Africa Eosinophilic Disease Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 49. U.S. Eosinophilic Disease Sales Quantity, 2018-2029, (K Units)
Figure 50. By Type, U.S. Eosinophilic Disease Sales Quantity Market Share, 2022 VS 2029
Figure 51. By Application, U.S. Eosinophilic Disease Sales Quantity Market Share, 2022 VS 2029
Figure 52. Europe Eosinophilic Disease Sales Quantity, 2018-2029, (K Units)
Figure 53. By Type, Europe Eosinophilic Disease Sales Quantity Market Share, 2022 VS 2029
Figure 54. By Application, Europe Eosinophilic Disease Sales Quantity Market Share, 2022 VS 2029
Figure 55. China Eosinophilic Disease Sales Quantity, 2018-2029, (K Units)
Figure 56. By Type, China Eosinophilic Disease Sales Quantity Market Share, 2022 VS 2029
Figure 57. By Application, China Eosinophilic Disease Sales Quantity Market Share, 2022 VS 2029
Figure 58. Japan Eosinophilic Disease Sales Quantity, 2018-2029, (K Units)
Figure 59. By Type, Japan Eosinophilic Disease Sales Quantity Market Share, 2022 VS 2029
Figure 60. By Application, Japan Eosinophilic Disease Sales Quantity Market Share, 2022 VS 2029
Figure 61. South Korea Eosinophilic Disease Sales Quantity, 2018-2029, (K Units)
Figure 62. By Type, South Korea Eosinophilic Disease Sales Quantity Market Share, 2022 VS 2029
Figure 63. By Application, South Korea Eosinophilic Disease Sales Quantity Market Share, 2022 VS 2029
Figure 64. Southeast Asia Eosinophilic Disease Sales Quantity, 2018-2029, (K Units)
Figure 65. By Type, Southeast Asia Eosinophilic Disease Sales Quantity Market Share, 2022 VS 2029
Figure 66. By Application, Southeast Asia Eosinophilic Disease Sales Quantity Market Share, 2022 VS 2029
Figure 67. India Eosinophilic Disease Sales Quantity, 2018-2029, (K Units)
Figure 68. By Type, India Eosinophilic Disease Sales Quantity Market Share, 2022 VS 2029
Figure 69. By Application, India Eosinophilic Disease Sales Quantity Market Share, 2022 VS 2029
Figure 70. Middle East & Africa Eosinophilic Disease Sales Quantity, 2018-2029, (K Units)
Figure 71. By Type, Middle East & Africa Eosinophilic Disease Sales Quantity Market Share, 2022 VS 2029
Figure 72. By Application, Middle East & Africa Eosinophilic Disease Sales Quantity Market Share, 2022 VS 2029
Figure 73. Research Methodology
Figure 74. Breakdown of Primary Interviews
Figure 75. Bottom-up and Top-down Approaches
Figure 76. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets